NewsEmmessar Biotech & Nutrition Limited confirms non-applicability of SEBI circular regarding funding by large corporatesEmmessar Biotech & Nutrition Limited confirms non-applicability of SEBI circular regarding funding by large corporates
Emmessar Biotech & Nutrition Limited confirmed to BSE that it does not qualify as a large corporate under SEBI circular dated October 19, 2023. The company reported nil outstanding borrowings as on March 31, 2025, with credit rating and fine provisions marked as not applicable. This regulatory disclosure ensures compliance while clarifying the company's status regarding SEBI's framework for funding by large corporates.
*this image is generated using AI for illustrative purposes only.
Emmessar biotech & Nutrition Limited has formally communicated to the Bombay Stock Exchange that it does not meet the criteria to be classified as a large corporate under the applicable SEBI regulations. The company submitted this confirmation on April 08, 2026, addressing the requirements under SEBI circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023.
Regulatory Compliance Disclosure
The company's disclosure relates to the SEBI framework concerning funding by large corporates, which establishes specific criteria for classification and compliance requirements. Emmessar Biotech & Nutrition Limited confirmed that it does not fall under the large corporate category as defined by the regulatory guidelines.
Financial Position Details
The company provided key financial and operational details as part of its regulatory submission:
| Parameter: | Details |
|---|---|
| Company Name: | Emmessar Biotech & Nutrition Ltd. |
| CIN: | L24110MH1992PLC065942 |
| Outstanding Borrowing (March 31, 2025): | NIL |
| Credit Rating Status: | Not Applicable |
| Stock Exchange Fine Provision: | Not Applicable |
The company reported nil outstanding borrowings as on March 31, 2025, which supports its position regarding non-applicability of the large corporate framework. Additionally, credit rating requirements and stock exchange fine provisions related to borrowing shortfalls are marked as not applicable to the company's current operational structure.
Corporate Information
Emmessar Biotech & Nutrition Limited operates from its registered office and factory located at Plot No. T-3/2, MIDC Area, Taloja, Maharashtra. The company maintains its corporate office at Kamer Building in Fort, Mumbai. The disclosure was signed by Priyanka Sharma, serving as Company Secretary and Compliance Officer, ensuring proper authorization and compliance with regulatory requirements.
Regulatory Framework Context
The SEBI circular referenced in the disclosure establishes guidelines for funding mechanisms involving large corporates. Companies meeting specific criteria under this framework are subject to particular compliance requirements, including borrowing thresholds and credit rating obligations. By confirming its non-applicability status, Emmessar Biotech & Nutrition Limited clarifies its regulatory position and ensures transparency with market participants and regulatory authorities.
Historical Stock Returns for Emmessar Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.39% | +3.33% | +5.01% | -19.10% | -19.25% | +48.73% |
What growth strategies might Emmessar Biotech pursue to potentially reach large corporate status in the coming years?
How could the company's zero borrowing position impact its ability to fund expansion in the competitive biotech and nutrition sector?
Will Emmessar Biotech consider debt financing or equity fundraising to accelerate growth given its current debt-free status?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
